New eye injection shows promise for blinding swelling
NCT ID NCT06664502
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new drug called EYE201, given as three eye injections over 12 weeks, to see if it is safe and can help reduce swelling in the back of the eye. It includes people with three different eye conditions that cause vision loss: branch retinal vein occlusion (BRVO), diabetic macular edema (DME), and wet age-related macular degeneration (NVAMD). The study first checks safety in a small group with BRVO, then compares two different doses in larger groups with DME or NVAMD.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRANCH RETINAL VEIN OCCLUSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Abilene, Texas
Abilene, Texas, 79606, United States
-
Amarillo, Texas
Amarillo, Texas, 79106, United States
-
Arecibo, PR
Arecibo, 00612, Puerto Rico
-
Asheville, NC
Asheville, North Carolina, 28803, United States
-
Austin, Texas
Austin, Texas, 78705, United States
-
Bellaire, TX
Bellaire, Texas, 77401, United States
-
Bellaire, Texas
Bellaire, Texas, 77401, United States
-
Bloomfield, New Jersey
Bloomfield, New Jersey, 07003, United States
-
Dallas, Texas
Dallas, Texas, 75231, United States
-
Deerfield Beach, FL
Deerfield Beach, Florida, 33064, United States
-
Germantown, Tennessee
Germantown, Tennessee, 38138, United States
-
Hagerstown, Maryland
Hagerstown, Maryland, 21740, United States
-
Knoxville, TN
Knoxville, Tennessee, 37922, United States
-
Lemont, IL
Lemont, Illinois, 60439, United States
-
Madison, Mississippi
Madison, Mississippi, 39110, United States
-
Modesto, CA
Modesto, California, 95356, United States
-
Mountain View, California
Mountain View, California, 94040, United States
-
Nashville, Tennessee
Nashville, Tennessee, 37203, United States
-
Plano, TX
Plano, Texas, 75075, United States
-
Round Rock, TX
Round Rock, Texas, 78681, United States
-
Sacramento, CA
Sacramento, California, 95825, United States
-
Sacramento, California
Sacramento, California, 95841, United States
-
San Antonio, Texas
San Antonio, Texas, 78240, United States
-
Scottsdale, Arizona
Scottsdale, Arizona, 85255, United States
-
Wake Forest, NC
Wake Forest, North Carolina, 27587, United States
-
West Columbia, South Carolina
West Columbia, South Carolina, 29169, United States
-
Woodlands, Texas
The Woodlands, Texas, 77384, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new eye injection beat the current standard for diabetic vision loss?
- Eye injection aims to tame leading causes of blindness
- AI could predict which eye treatments work best for Diabetes-Related vision loss
- New eye drug EYE103 takes on lucentis in major trial for Diabetes-Related vision loss
- New dosing strategy could mean fewer eye injections for Diabetes-Related vision loss
- New syringe could simplify High-Dose eye treatment